Anavex Life Sciences (AVXL) Return on Invested Capital (2017 - 2025)

Anavex Life Sciences' Return on Invested Capital history runs 9 years deep, the most recent figure standing at 0.0% for Q4 2025.

• In Q4 2025, Return on Invested Capital changed N/A year-over-year to 0.0%; the TTM figure through Dec 2025 stood at 0.0% (changed N/A YoY), while the FY2023 annual figure was 0.0%, changed 0.0% from the prior year.
• Return on Invested Capital came in at 0.0% for Q4 2025 at Anavex Life Sciences, down from 0.0% in the prior quarter.
• In the past five years, Return on Invested Capital ranged from a high of 0.0% in Q3 2021 to a low of 0.0% in Q1 2021.
• A 5-year average of 0.0% and a median of 0.0% in 2023 frame the typical range for Return on Invested Capital.
• On a YoY basis, Return on Invested Capital climbed as much as 1 bps in 2021 and fell as far as 0 bps in 2021.
• Anavex Life Sciences' Return on Invested Capital stood at 0.0% in 2021, then tumbled by 41 bps to 0.0% in 2022, then rose by 6 bps to 0.0% in 2023, then dropped by 4 bps to 0.0% in 2024, then retreated by 2 bps to 0.0% in 2025.
• According to Business Quant data, Return on Invested Capital over the past three periods registered 0.0%, 0.0%, and 0.0% for Q4 2025, Q2 2024, and Q1 2024 respectively.

Peer Comparison